May 13, 2021
Arizona, Arizona Department of Health Services, AZ, cannabis businesses, cannabis establishments, cannabis legalization, communities disproportionately impacted, draft rules, eligibility criteria, enforcement, implementation, legalization, online survey, Prop 207, public comments, public input, regulators, social equity, social equity licensing program
Feb 19, 2021
Arizona, automatic expungement, cannabis convictions, cannabis legalization, cannabis regulation, Colorado, community reinvestment, Gov. Michelle Lujan Grisham, HB 12, home cultivation, House Health and Human Services Committee, New Mexico, NM, personal possession, polling, Rep. Javier Martinez, Tax and Regulate, tax revenue
Oct 20, 2020
Alternative 65A, Amendment A, Arizona, ballot, ballot initiatives, cannabis reform ballot initiatives, CI-118, Congress, Election Day, I-190, Initiated Measure 26, Initiative 65, Mississippi, Montana, New Jersey, Prop. 207, Public Question 1, South Dakota
Oct 13, 2020
adult-use legalization ballot initiatives, Amendment A, Arizona, ballot initiatives, cannabis legalization, Chuck Parkinson, Election Day, endorsements, ESPN, Initiated Measure 26, Jeff Thurn, medical cannabis, Mississippi, Montana, New Jersey, SD, South Dakota, South Dakotans for Better Marijuana Laws, Tom Daschle, vote
Jan 23, 2018
Arizona, HB 2014, HB 2068, Mark Cardenas, SB 1060, Supreme Court
Nov 15, 2016
Arizona, California, Congress, District of Columbia, Donald Trump, legalization, Maine, Massachusetts, Nevada, Trump
Nov 08, 2016
Arizona, Arkansas, California, Delaware, District of Columbia, Florida, Illinois, Maine, Massachusetts, Montana, Nebraska, Nevada, New Hampshire, North Dakota, Pennsylvania, South Carolina, Vermont, voter guides
Oct 06, 2016
Arizona, Arizonans for Responsible Drug Policy, Campaign to Regulate Marijuana like Alcohol, Insys Therapeutics, Phoenix, prop 205
Sep 30, 2016
Arizona, California, Maine, Massachusetts, Nevada
Sep 27, 2016
Arizona, Arizonans for Responsible Drug Policy, Chandler, CNBC, fentanyl, Insys Therapeutics, prop 205

